Trial Profile
A Phase I/II Study of the Safety of CD34+ Haematopoietic Stem/Progenitor Cells and CD4+ T Lymphocytes Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct, in HIV-1 Infected Patients With High-risk Lymphoma
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Cal 1 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms GENHIV
- 26 Jul 2018 New trial record